Increased leukocyte aggregates are associated with atherosclerosis in patients with hemodialysis

Hemodialysis International

Volumn 13, Issue 3, 2009, Pages 286-292

  Kobayashi, Shuzo ^a   Miyamoto, Mitsuko ^b   Kurumatani, Hajime ^b   Oka, Machiko ^a   Maesato, Kyoko ^a   Mano, Tsutomu ^a   Ikee, Ryota ^a   Moriya, Hidekazu ^a   Ohtake, Takayasu ^a  

^a SHONAN KAMAKURA GENERAL HOSPITAL   (Japan)

^b TORAY INDUSTRIES INC   (Japan)

Author keywords

Aortic stiffness; Hemodialysis; Hemorheology; Platelet leukocyte aggregation

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN;

ADULT; AGED; ANKLE BRACHIAL INDEX; ARTERIAL STIFFNESS; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; BLOOD FLOW; FEMALE; FIBRINOGEN BLOOD LEVEL; FLOW CYTOMETRY; HEMODIALYSIS PATIENT; HUMAN; HYPERTENSION; LEUKOCYTE AGGREGATION; MAJOR CLINICAL STUDY; NONHUMAN; PULSE WAVE; SMOKING;

ADULT; AGED; AGED, 80 AND OVER; ATHEROSCLEROSIS; BLOOD PLATELETS; BLOOD VISCOSITY; CELL AGGREGATION; FEMALE; FLOW CYTOMETRY; HUMANS; LEUKOCYTES; MALE; MIDDLE AGED; PLATELET AGGREGATION; RENAL DIALYSIS; RHEOLOGY;

EID: 69249192975     PISSN: 14927535     EISSN: 15424758     Source Type: Journal    
DOI: 10.1111/j.1542-4758.2009.00371.x     Document Type: Article

References (27)

1. Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal failure. Am J Kidney Dis. 1998; 32(Suppl 3):112-119.
2. London GM, Druek T. Atherosclerosis and arteriosclerosis in chronic renal failure. Kidney Int. 1997; 51:1678-1695.
3. Ross R. Atherosclerosis-An inflammatory disease. N Engl J Med. 1999; 340:115-126.
4. Zimmermann J, Herrlinger S, Pruy A, et al. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int. 1999; 55:648-658.
5. Yeun JY, Levine RA, Mantadilok V, et al. C-reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients. Am J Kidney Dis. 2000; 35:469-476.
6. Arici M, Walls J. End-stage renal disease, atherosclerosis, and cardiovascular mortality: Is C-reactive protein the missing link? Kidney Int. 2001; 59:407-414.
7. Verma S, Buchanan MR, Anderson TJ. Endothelial function testing as a biomarker of vascular disease. Circulation. 2003; 108:2054-2059.
8. Gawaz MP, Mujais SK, Schmidt B, et al. Platelet-leukocyte aggregates during hemodialysis: Effect of membrane type. Artif Organs. 1999; 23:29-36.
9. Kobayashi S, Okamoto K, Maesato K, et al. Important role of blood rheology in atherosclerosis of patients with hemodialysis. Hemodial Int. 2005; 9:268-274.
10. Kikuchi Y, Sato K, Ohki H. Optically accessible microchannels formed in a single-crystal silicon substrate for studies of blood rheology. Microvasc Res. 1992; 4:226-240.
11. Kikuchi Y, Sato K, Mizoguchi Y. Modified cell-flow microchannels in a single-crystal silicon substrate and flow behavior of blood cells. Microvasc Res. 1994; 47:126-139.
12. Kurihara T, Deguchi S, Kato J. Impaired blood rheology by remnant-like lipoprotein particles: Studies in patients with fatty liver disease. Clin Hematol Microcirc. 2001; 24:217-225.
13. Kobayashi S, Moriya H, Aso K, et al. Vitamin E-bonded hemodialyzer improves atherosclerosis associated with a rheological improvement of circulating red blood cells. Kidney Int. 2003; 63:1881-1887.
14. Lehmann ED. Clinical value of aortic pulse-wave velocity measurement. Lancet. 1999; 354:528-529.
15. Yamashina A, Tomiyama H, Takeda K, et al. Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement. Hypertens Res. 2002; 25:359-364.
16. Furman MI, Benoit SE, Barnard MR, et al. Increased platelet reactivity and circulating monocyte-platelet aggregates in patients with stable coronary artery disease. J Am Coll Cardiol. 1998; 31:352-358.
17. Michelson AD, Barnard MR, Krueger LA, et al. Circulating monocyte-platelet aggregates are a more sensitive marker of in vivo platelet activation than platelet surface P-selectin. Studies in baboons, human coronary intervention, and human acute myocardial infarction. Circulation. 2001; 104:1533-1537.
18. Ashman N, Macey MG, Fan SL, et al. Increased platelet-monocyte aggregates and cardiovascular disease in end-stage renal failure patients. Nephrol Dial Transplant. 2003; 18:2088-2096.
19. Szmitko PE, Wang CH, Weisel RD, De Almeida JR, Anderson TJ, Verma S. New markers of inflammation and endothelial cell activation Part I. Circulation. 2003; 108:1917-1923.
20. Szmitko PE, Wang CH, Weisel RD, et al. Biomarkers of vascular disease linking inflammation to endothelial activation Part II. Circulation. 2003; 108:2041-2048.
21. Faint RW. Platelet-neutrophil interactions: Their significance. Blood Rev. 1992; 6:83-91.
22. Bazzoni G, Dejana E, Del Maschio A. Platelet neutrophil interactions. Possible relevance in the pathogenesis of thrombosis and inflammation. Haematologica. 1991; 76:491-499.
23. Hakim RM, Schafer AI. Hemodialysis-associated platelet activation and thrombocytopenia. Am J Med. 1985; 78:575-580.
24. Ware JA, Heistad DD. Platelet endothelium interactions. N Engl J Med. 1993; 328:628-635.
25. Kenney KR. Rheology: Overlooked component of vascular disease. Clin Appl Thrombosis/Hemostasis. 2003; 9:93-99.
26. Lee AJ, Mowbray PI, Lowe GDO. Blood viscosity and elevated carotid intima-media thickness in men and women. The Edinburgh Artery Study. Circulation. 1998; 97:1467-1473.
27. Giachelli CM, Lombardi D, Johnson RJ. Evidence for a role of osteopontin in macrophage infiltration in response to pathological stimuli in vivo. Am J Pathol. 1998; 152:353-358.